U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07886450) titled 'Oculomotor-Pupillary AI Biomarkers in Parkinson's' on Oct. 01.
Brief Summary: The goal of this prospective observational study is to investigate whether oculomotor-pupillary abnormalities detected using a novel edge-AI eye-tracking device can serve as objective and quantitative biomarkers for the early screening and clinical evaluation of Parkinson's disease (PD). The study will include individuals with early-to-moderate PD and healthy controls. The main question it aims to answer is:
Can oculomotor-pupillary abnormalities detected by a novel edge-AI eye-tracking device serve as objective and quantitative biomarkers for the early s...